Seroconversion for cytomegalovirus infection in a cohort of pregnant women in Québec, 2010-2013

V Lamarre, N L Gilbert, C Rousseau, T W Gyorkos, W D Fraser, V Lamarre, N L Gilbert, C Rousseau, T W Gyorkos, W D Fraser

Abstract

Cytomegalovirus (CMV) is the leading cause of congenital infection and non-genetic sensorineural hearing loss in children. There are no recent data on the incidence of CMV infection during pregnancy in Canada. This present study was undertaken to determine the seroprevalence of CMV IgG antibodies and the rate of seroconversion in a cohort of pregnant women in the province of Québec, Canada. We used serum samples and questionnaire data collected as part of the 3D Pregnancy and Birth Cohort Study (2010-2013) conducted in Québec, Canada. CMV IgG antibodies were determined in serum samples collected at the first and third trimesters. Associations between independent variables and seroprevalence were assessed using logistic regression, and associations with seroconversions, by Poisson regression. Of 1938 pregnant women tested, 40·4% were seropositive for CMV at baseline. Previous CMV infection was associated with: working as a daycare educator, lower education, lower income, having had children, first language other than French or English, and being born outside Canada or the United States. Of the 1122 initially seronegative women, 24 (2·1%) seroconverted between their first and third trimesters. The seroconversion rate was 1·4 [95% confidence interval (CI) 0·9-2·1]/10 000 person-days at risk or 3·9 (95% CI 2·5-5·9)/100 pregnancies (assuming a 280-day gestation). The high proportion of pregnant women susceptible to CMV infection (nearly 60%) and the subsequent rate of seroconversion are of concern.

Keywords: Cytomegalovirus; infectious disease epidemiology; pregnancy; prevention; serology.

References

    1. Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Reviews in Medical Virology 2007; 17: 253–276.
    1. Larke RP, et al. Congenital cytomegalovirus infection in an urban Canadian community. Journal of Infectious Diseases 1980; 142: 647–653.
    1. Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Reviews in Medical Virology 2007; 17: 355–363.
    1. Britt W. Cytomegalovirus. In: Remington JS, et al. eds. Infectious Diseases of the Fetus and Newborn, 8th edn. Philadelphia, PA, USA: Elsevier, 2015, pp. 724–781.
    1. Stagno S, et al. Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. Journal of the American Medical Association 1986; 256: 1904–1908.
    1. Picone O, et al. A series of 238 cytomegalovirus primary infections during pregnancy: description and outcome. Prenatal Diagnosis 2013; 33: 751–758.
    1. Fowler KB, et al. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. New England Journal of Medicine 1992; 326: 663–667.
    1. Adler SP. Cytomegalovirus and child day care. Evidence for an increased infection rate among day-care workers. New England Journal of Medicine 1989; 321: 1290–1296.
    1. Sohn YM, et al. Cytomegalovirus infection in sexually active adolescents. Journal of Infectious Diseases 1991; 163: 460–463.
    1. Marshall BC, Adler SP. The frequency of pregnancy and exposure to cytomegalovirus infections among women with a young child in day care. American Journal of Obstetrics and Gynecology 2009; 200: 163.
    1. Pass RF, et al. Increased rate of cytomegalovirus infection among day care center workers. Pediatric Infectious Disease Journal 1990; 9: 465–470.
    1. Ford-Jones EL, et al. Cytomegalovirus infections in Toronto child-care centers: a prospective study of viral excretion in children and seroconversion among day-care providers. Pediatric Infectious Disease Journal 1996; 15: 507–514.
    1. Joseph SA, et al. Risk factors for cytomegalovirus seropositivity in a population of day care educators in Montréal, Canada. Occupational Medicine 2005; 55: 564–567.
    1. Dollard SC, et al. National prevalence estimates for cytomegalovirus IgM and IgG avidity and association between high IgM antibody titer and low IgG avidity. Clinical and Vaccine Immunology 2011; 18: 1895–1899.
    1. Fraser W, et al. 3-D Study: The Integrated Research Network in Perinatology of Quebec and Eastern Ontario (IRNPQEO). Canadian National Perinatal Research Meeting Banff, Canada, 2014.
    1. Ulm K. A simple method to calculate the confidence interval of a standardized mortality ratio (SMR). American Journal of Epidemiology 1990; 131: 373–375.
    1. Dowd JB, Aiello AE, Alley DE. Socioeconomic disparities in the seroprevalence of cytomegalovirus infection in the US population: NHANES III. Epidemiology and Infection 2009; 137: 58–65.
    1. Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Reviews in Medical Virology 2010; 20: 202–213.
    1. Plante R, Malenfant R. Reproductive health and work: different experiences. Journal of Occupational and Environmental Medicine 1998; 40: 964–968.
    1. Hyde TB, Schmid DS, Cannon MJ. Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV. Reviews in Medical Virology 2010; 20: 311–326.
    1. Duchesne L. The demographic situation in Québec – Report 1999. Québec's Institute of Statistics, 2000.
    1. Girard C. Births and fecundity. In: Girard C, et al. eds. Québec's Demographical Report, 2014 edition. Québec, Canada: Québec's Institute of Statistics, 2014, pp. 41–58.
    1. Rose R. Women and the workplace in Québec: statistical portrait. Montréal, Québec, Canada: Consultative committee Women in workforce development, 2013.
    1. Giguère C, Desrosiers H. Care settings from birth to 8 years of age: use and effect on the development of children, volume 5 part 1. In: Longitudinal Study of the Development of Québec's Children (ELDEQ 1998–2010) – from Birth to 8 Years of Age. Québec, Canada: Québec's Institute of Statistics, 2010.
    1. Wizman S, et al. Risk factors for cytomegalovirus susceptibility among pregnant women: an epidemiological and socio-demographic study. IDWeek 2013. San Francisco, CA, USA, 2013; Abstract 1782.
    1. Price SM, et al. Educating women about congenital cytomegalovirus: assessment of health education materials through a web-based survey. BMC Women's Health 2014; 14: 144.
    1. American College of Obstetricians and Gynecologists. Practice bulletin no. 151: Cytomegalovirus, parvovirus B19, varicella zoster, and toxoplasmosis in pregnancy. Obstetrics and Gynecology 2015; 125: 1510–1525.
    1. Society of Obstetricians and Gynaecologists of Canada. Cytomegalovirus infection in pregnancy. Journal of Obstetrics and Gynaecology Canada 2010; 32: 248–354.
    1. Adler SP, et al. Prevention of child-to-mother transmission of cytomegalovirus by changing behaviors: a randomized controlled trial. Pediatric Infectious Disease Journal 1996; 15: 240–246.
    1. Adler SP, et al. Prevention of child-to-mother transmission of cytomegalovirus among pregnant women. Journal of Pediatrics 2004; 145: 485–491.
    1. Public Health Agency of Canada. What Mothers Say: the Canadian Maternity Experiences Survey. Ottawa, Canada, 2009, 225 pp.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa